Exact Mass: 446.2562778
Exact Mass Matches: 446.2562778
Found 500 metabolites which its exact mass value is equals to given mass value 446.2562778
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
SR 49498
C25H30N6O2 (446.24301199999996)
SR 49498 is a metabolite of Irbesartan. Sr 49498 belongs to the family of Aromatic Homomonocyclic Compounds. These are aromatic compounds containig only one ring, which is homocyclic.
Tert-butyl (2-{7-[(2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}ethyl)carbamate
Erdafitinib
C25H30N6O2 (446.24301199999996)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Fluocortin butyl
Trilaciclib
C24H30N8O (446.25424499999997)
2-[(E)-3,7-dimethylocta-2,6-dienyl]-5-(6-hydroxy-1-benzofuran-2-yl)-4-(3-methylbut-2-enyl)benzene-1,3-diol|artopetelin B
3,7,18-O-triacetylfoliol|3,7,18-triacetylfoliol|3alpha,7beta,18-triacetoxy-ent-kaur-16-ene|foliol triacetate|Triacetylfoliol
methyl-3beta,9beta-dihydroxy-15alpha-senecioyloxy-ent-kaurenoate
methyl-3beta,9beta-dihydroxy-15alpha-angeloyloxy-ent-kaurenoate
2alpha-Angeloyloxy-3beta-(2-methylpent-2-enoylxy)isodrimeninol
methyl ent-7alpha,9alpha-dihydroxy-15beta-[(2Z)-2-methyl-but-2-enoyloxy]kaur-16-en-19-oate|Methyl ent-7??,9??-dihydroxy-15??-[(2Z)-2-methyl-but-2-enoyloxy]kaur-16-en-19-oate
methyl-9beta,11beta-dihydroxy-15alpha-angeloyloxy-ent-kaurenoate
2-[(2E)-3,7-dimethylocta-2,6-dienyl]-2-(3-methylbut-2-enyl)dibenzo[b,f]oxepin-3,7,10-triol|artocarpol E
espinasanolide-(2-methylbutyrate) methyl ester|espinasanolide-<2-methylbutyrate> methyl ester
3alpha,9beta,13alpha-trihydroxy-11(12),15(17)-trinervitadiene-3,9,13-triacetate
berkeleyone A
A meroterpenoid found in Penicillium rubrum and has been shown to exhibit inhibitory activity against caspase-1.
(Z)-2-(3-hydroxy-4-(6-methylhept-2-en-2-yl)benzyl)-5-(3-hydroxy-5-methylphenoxy)-3-methylphenol|expansol C
(Z)-2-(3-hydroxy-4-(6-methylhept-2-en-2-yl)benzyl)-3-(3-hydroxy-5-methylphenoxy)-5-methylphenol|expansol E
(1aR,4R,7S,7aR,7bR)-1a,2,4,5,6,7,7a,7b-octahydro-1a-[1-(hydroxymethyl)ethenyl]-7,7a-dimethyl-2-oxonaphth[1,2-b]oxiren-4-yl (4E)-3-hydroxy-2,4,6-trimethyloct-4-enoate|1-(xylarenone A)xylariate A
1(15),8(19)-trinervitadiene-2beta,3alpha,14alpha triacetate|Tri-Ac-(2beta,3alpha,14alpha)-1(15),8(19)-Trinervitadiene-2,3,14-triol
2beta,3alpha,9alpha-triacetoxy-1(15),8(19)-trinervitadiene
7alpha-acetyl-isopimara-8(14),15-dien-18-yl and metyl malonate
2-O-acetyl-3-O-isobutyryl-4-O-isocaprylglucopyranose
1(15),8(19)-trinervitadiene-2beta,3alpha,13alpha triacetate
Val Thr Ile Asp
C26H38O6_Androsta-11,15-diene-14-carboxylic acid, 3,15,19-trihydroxy-4,4,8,12,16-pentamethyl-17-oxo-, methyl ester
Lovastatin putative derivative C26H38O6 observed in fungal symbiont H
Ala Phe Ile Pro
Ala Phe Leu Pro
Ala Phe Pro Ile
Ala Phe Pro Leu
Ala Ile Phe Pro
Ala Ile Ile Met
Ala Ile Leu Met
Ala Ile Met Ile
Ala Ile Met Leu
Ala Ile Pro Phe
Ala Lys Gln Thr
Ala Lys Thr Gln
Ala Leu Phe Pro
Ala Leu Ile Met
Ala Leu Leu Met
Ala Leu Met Ile
Ala Leu Met Leu
Ala Leu Pro Phe
Ala Met Ile Ile
Ala Met Ile Leu
Ala Met Leu Ile
Ala Met Leu Leu
Ala Pro Phe Ile
Ala Pro Phe Leu
Ala Pro Ile Phe
Ala Pro Leu Phe
Ala Gln Lys Thr
Ala Gln Thr Lys
Ala Thr Lys Gln
Ala Thr Gln Lys
Cys Ile Ile Val
Cys Ile Leu Val
Cys Ile Val Ile
Cys Ile Val Leu
Cys Leu Ile Val
Cys Leu Leu Val
Cys Leu Val Ile
Cys Leu Val Leu
Cys Val Ile Ile
Cys Val Ile Leu
Cys Val Leu Ile
Cys Val Leu Leu
Asp Gly Lys Lys
Asp Ile Ile Ser
Asp Ile Leu Ser
Asp Ile Ser Ile
Asp Ile Ser Leu
Asp Ile Thr Val
Asp Ile Val Thr
Asp Lys Gly Lys
Asp Lys Lys Gly
Asp Leu Ile Ser
Asp Leu Leu Ser
Asp Leu Ser Ile
Asp Leu Ser Leu
Asp Leu Thr Val
Asp Leu Val Thr
Asp Ser Ile Ile
Asp Ser Ile Leu
Asp Ser Leu Ile
Asp Ser Leu Leu
Asp Thr Ile Val
Asp Thr Leu Val
Asp Thr Val Ile
Asp Thr Val Leu
Asp Val Ile Thr
Asp Val Leu Thr
Asp Val Thr Ile
Phe Ala Ile Pro
Phe Ala Leu Pro
Phe Ala Pro Ile
Phe Ala Pro Leu
Phe Ile Ala Pro
Phe Ile Pro Ala
Phe Leu Ala Pro
Phe Leu Pro Ala
Phe Pro Ala Ile
Phe Pro Ala Leu
Phe Pro Ile Ala
Phe Pro Leu Ala
Gly Asp Lys Lys
Gly Lys Asp Lys
Gly Lys Lys Asp
Gly Lys Arg Ser
Gly Lys Ser Arg
Gly Arg Lys Ser
Gly Arg Ser Lys
Gly Ser Lys Arg
Gly Ser Arg Lys
Ile Ala Phe Pro
Ile Ala Ile Met
Ile Ala Leu Met
Ile Ala Met Ile
Ile Ala Met Leu
Ile Ala Pro Phe
Ile Cys Ile Val
Ile Cys Leu Val
Ile Cys Val Ile
Ile Cys Val Leu
Ile Phe Ala Pro
Ile Phe Pro Ala
Ile Ile Ala Met
Ile Ile Cys Val
Ile Ile Met Ala
Ile Ile Thr Thr
Ile Ile Val Cys
Ile Leu Ala Met
Ile Leu Cys Val
Ile Leu Met Ala
Ile Leu Thr Thr
Ile Leu Val Cys
Ile Met Ala Ile
Ile Met Ala Leu
Ile Met Ile Ala
Ile Met Leu Ala
Ile Pro Ala Phe
Ile Pro Phe Ala
Ile Thr Ile Thr
Ile Thr Leu Thr
Ile Thr Thr Ile
Ile Thr Thr Leu
Ile Val Cys Ile
Ile Val Cys Leu
Ile Val Ile Cys
Ile Val Leu Cys
Lys Ala Gln Thr
Lys Ala Thr Gln
Lys Asp Gly Lys
Lys Asp Lys Gly
Lys Gly Asp Lys
Lys Gly Lys Asp
Lys Gly Arg Ser
Lys Gly Ser Arg
Lys Lys Asp Gly
Lys Lys Gly Asp
Lys Asn Ser Val
Lys Asn Val Ser
Lys Gln Ala Thr
Lys Gln Thr Ala
Lys Arg Gly Ser
Lys Arg Ser Gly
Lys Ser Gly Arg
Lys Ser Asn Val
Lys Ser Arg Gly
Lys Ser Val Asn
Lys Thr Ala Gln
Lys Thr Gln Ala
Lys Val Asn Ser
Lys Val Ser Asn
Leu Ala Phe Pro
Leu Ala Ile Met
Leu Ala Leu Met
Leu Ala Met Ile
Leu Ala Met Leu
Leu Ala Pro Phe
Leu Cys Ile Val
Leu Cys Leu Val
Leu Cys Val Ile
Leu Cys Val Leu
Leu Asp Leu Ser
Leu Asp Ser Ile
Leu Asp Ser Leu
Leu Asp Thr Val
Leu Asp Val Thr
Leu Glu Ser Val
Leu Glu Val Ser
Leu Phe Ala Pro
Leu Phe Pro Ala
Leu Ile Ala Met
Leu Ile Cys Val
Leu Ile Asp Ser
Leu Ile Met Ala
Leu Ile Ser Asp
Leu Ile Thr Thr
Leu Ile Val Cys
Leu Leu Ala Met
Leu Leu Cys Val
Leu Leu Asp Ser
Leu Leu Met Ala
Leu Leu Ser Asp
Leu Leu Thr Thr
Leu Leu Val Cys
Leu Met Ala Ile
Leu Met Ala Leu
Leu Met Ile Ala
Leu Met Leu Ala
Leu Pro Ala Phe
Leu Pro Phe Ala
Leu Ser Asp Ile
Leu Ser Asp Leu
Leu Ser Glu Val
Leu Ser Ile Asp
Leu Thr Ile Thr
Leu Thr Leu Thr
Leu Thr Thr Ile
Leu Thr Thr Leu
Leu Val Cys Ile
Leu Val Cys Leu
Leu Val Ile Cys
Leu Val Leu Cys
Met Ala Ile Ile
Met Ala Ile Leu
Met Ala Leu Ile
Met Ala Leu Leu
Met Ile Ala Ile
Met Ile Ala Leu
Met Ile Ile Ala
Met Ile Leu Ala
Met Leu Ala Ile
Met Leu Ala Leu
Met Leu Ile Ala
Met Leu Leu Ala
Met Val Val Val
Asn Lys Ser Val
Asn Lys Val Ser
Asn Ser Lys Val
Asn Ser Val Lys
Asn Val Lys Ser
Asn Val Ser Lys
Pro Ala Phe Ile
Pro Ala Phe Leu
Pro Ala Ile Phe
Pro Ala Leu Phe
Pro Phe Ala Ile
Pro Phe Ala Leu
Pro Phe Ile Ala
Pro Phe Leu Ala
Pro Ile Ala Phe
Pro Ile Phe Ala
Pro Leu Ala Phe
Pro Leu Phe Ala
Gln Ala Lys Thr
Gln Ala Thr Lys
Gln Lys Ala Thr
Gln Lys Thr Ala
Gln Thr Ala Lys
Gln Thr Lys Ala
Arg Gly Lys Ser
Arg Gly Ser Lys
Arg Lys Gly Ser
Arg Lys Ser Gly
Arg Ser Gly Lys
Arg Ser Lys Gly
Ser Gly Lys Arg
Ser Gly Arg Lys
Ser Lys Gly Arg
Ser Lys Asn Val
Ser Lys Arg Gly
Ser Lys Val Asn
Ser Asn Lys Val
Ser Asn Val Lys
Ser Arg Gly Lys
Ser Arg Lys Gly
Ser Val Lys Asn
Ser Val Asn Lys
Thr Ala Lys Gln
Thr Ala Gln Lys
Thr Ile Ile Thr
Thr Ile Leu Thr
Thr Ile Thr Ile
Thr Ile Thr Leu
Thr Lys Ala Gln
Thr Lys Gln Ala
Thr Leu Ile Thr
Thr Leu Leu Thr
Thr Leu Thr Ile
Thr Leu Thr Leu
Thr Gln Ala Lys
Thr Gln Lys Ala
Thr Thr Ile Ile
Thr Thr Ile Leu
Thr Thr Leu Ile
Thr Thr Leu Leu
Val Cys Ile Ile
Val Cys Ile Leu
Val Cys Leu Ile
Val Cys Leu Leu
Val Ile Cys Ile
Val Ile Cys Leu
Val Ile Ile Cys
Val Ile Leu Cys
Val Ile Ser Glu
Val Ile Thr Asp
Val Lys Asn Ser
Val Lys Ser Asn
Val Leu Cys Ile
Val Leu Cys Leu
Val Leu Glu Ser
Val Leu Ile Cys
Val Leu Leu Cys
Val Leu Ser Glu
Val Leu Thr Asp
Val Met Val Val
Val Asn Lys Ser
Val Asn Ser Lys
Val Ser Glu Ile
Val Ser Glu Leu
Val Ser Lys Asn
Val Ser Leu Glu
Val Ser Asn Lys
Val Thr Asp Ile
Val Thr Asp Leu
Val Thr Glu Val
Val Thr Leu Asp
Val Thr Val Glu
Val Val Glu Thr
Val Val Met Val
Val Val Thr Glu
Val Val Val Met
(2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl)amino-3-hydroxy-5-amino-1,6-diphenylhexane
(S)-(-)-2,2-Bis(di-i-propylphosphino)-6,6-dimethoxy-1,1-biphenyl,min.
(6,6-Dimethoxy-2,2-biphenyldiyl)bis(diisopropylphosphine)
Hydrocortisone Valerate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
1-pentanoylamino-cyclopentanecarboxylic acid [2-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide
C25H30N6O2 (446.24301199999996)
Trilaciclib
C24H30N8O (446.25424499999997)
V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AF - Detoxifying agents for antineoplastic treatment C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
N2-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine
C24H30N8O (446.25424499999997)
tert-butyl N-[2-[7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diazabicyclo[3.3.1]nonan-3-yl]ethyl]carbamate
[11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] pentanoate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
N2-(L-Phenylalanyl)-N1-(naphthalenyl)-L-arigninamide
C25H30N6O2 (446.24301199999996)
Fluocortin butyl
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D003879 - Dermatologic Agents
(5s,8r,9s,10s,13r,14s,17s)-13-{2-[(3,5-Difluorobenzyl)oxy]ethyl}-17-Hydroxy-10-Methylhexadecahydro-3h-Cyclopenta[a]phenanthren-3-One
Erdafitinib
C25H30N6O2 (446.24301199999996)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
[(17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] pentanoate
N-[2-[1-[(4-methoxy-3-methylphenyl)methyl]-4-piperidinyl]-3-pyrazolyl]-4-phenylbutanamide
2-[(3S,6aR,8R,10aR)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
Asp-Leu-Leu-Ser
A tetrapeptide composed of L-aspartic acid, two L-leucine units and L-serine joined in sequence by peptide linkages.
2-[(3S,6aS,8R,10aS)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3R,6aR,8R,10aR)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-piperidin-1-ylethanone
2-[(3S,6aR,8S,10aR)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
(3R,4Z,12R,15S)-17-Tert-butyl-14-(3-hydroxypropyl)-8-methyl-2,9-dioxa-14,17-diazatetracyclo[10.8.0.01,15.03,11]icosa-4,19-diene-10,13,16-trione
2-[(3R,6aR,8S,10aR)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3R,6aS,8S,10aS)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3S,6aS,8S,10aS)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
1-[2-[4-[(8S,9R,10R)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[2-[4-[(8R,9S,10S)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[2-[4-[(8S,9S,10S)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[(8R,9S,10R)-9-[4-[3-(dimethylamino)prop-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-(2-pyridinyl)ethanone
2-[(2R,4aR,12aS)-5-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-propylacetamide
2-[(3R,6aS,8R,10aS)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
1-[2-[4-[(8R,9R,10R)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[2-[4-[(8R,9R,10S)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[2-[4-[(8S,9S,10R)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[2-[4-[(8R,9S,10R)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[2-[4-[(8S,9R,10S)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
[(4E,8E,12E)-2-acetamido-3-hydroxytetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
5-(6-hydroxy-1-benzofuran-2-yl)-4-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,3-diol
4-[(1e)-2-[(1r,2r,3s,4r,4ar,8as)-2,3-dihydroxy-4-{[(2s)-2-isopropyloxiran-2-yl]methoxy}-1,2,4a,5-tetramethyl-4,7,8,8a-tetrahydro-3h-naphthalen-1-yl]ethenyl]-5h-furan-2-one
5-hydroxy-1,8a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydro-1h-naphthalen-2-yl 5-[(2-methylbut-2-enoyl)oxy]hex-2-enoate
1a-(3-hydroxyprop-1-en-2-yl)-7,7a-dimethyl-2-oxo-4h,5h,6h,7h,7bh-naphtho[1,2-b]oxiren-4-yl 3-hydroxy-2,4,6-trimethyloct-4-enoate
(1r,2r,4as,5r,8ar)-5-hydroxy-1,8a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydro-1h-naphthalen-2-yl (2z,5r)-5-{[(2z)-2-methylbut-2-enoyl]oxy}hex-2-enoate
3-benzyl-5,11-dihydroxy-6,9,12-triisopropyl-1,7-dioxa-4,10-diazacyclododeca-4,10-diene-2,8-dione
4-(3,7-dimethylocta-2,6-dien-1-yl)-5-(6-hydroxy-1-benzofuran-2-yl)-6-(3-methylbut-2-en-1-yl)benzene-1,3-diol
(1r,4s,11r)-11-hydroxy-7-(hydroxymethyl)-4-(4-methoxy-4-methylpent-2-en-1-yl)-4,11-dimethyl-8-oxocycloundeca-2,6,9-trien-1-yl 3-methylbut-2-enoate
(1r,6s,7r,10r,11r,12s,15s)-7,10-bis(acetyloxy)-6,12,16-trimethyl-2-methylidenetricyclo[7.5.2.0¹²,¹⁵]hexadec-9(16)-en-11-yl acetate
methyl (1s,4s,5s,6s,9r,10r,13r,15s)-6,10-dihydroxy-5,9-dimethyl-15-{[(2e)-2-methylbut-2-enoyl]oxy}-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
18-o-methylvibsanin g
{"Ingredient_id": "HBIN002147","Ingredient_name": "18-o-methylvibsanin g","Alias": "NA","Ingredient_formula": "C26H38O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14799","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}